Covenant Partners’s Johnson & Johnson JNJ Stock Holding History

Covenant Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,622	Closed	-$365K	–	190
2019 Q2	$365K	Hold	2,622	–	–	0.19%	126
2019 Q1	$367K	Buy	+2,622	New	+$351K	0.2%	122

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Covenant Partners's JNJ Position: Q3 2019 in Review

Covenant Partners sold out of Johnson & Johnson (JNJ) in Q3 2019, closing a stake of 2,622 shares — an estimated $365K sold.

Covenant Partners first reported a position in JNJ in Q1 2019 and held it in 2 quarters. The position peaked at $367K in Q1 2019. 2,724 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

Covenant Partners reported no remaining Johnson & Johnson position as of Q3 2019 after selling out during the quarter.
Covenant Partners sold 2,622 Johnson & Johnson shares in Q3 2019, an estimated $365K.
Covenant Partners first reported a position in Johnson & Johnson in Q1 2019 and held it in 2 quarters.
Covenant Partners's Johnson & Johnson position peaked at $367K in Q1 2019.
2,724 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on Covenant Partners's 13F filing for Q3 2019, filed 14 Nov 2019.